Pharmacists should be aware of the following side effects to properly advise and help patients manage accordingly: Hypoglycaemia consider dose reduction of concomitant medications, particularly sulfonylurea and insulin, to prevent hypoglycaemia if this a concern
(3) Contraindications History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) (4) During or within 14 days following the administration of monoamine oxidase inhibitors (4) Hyperthyroidism (4) Glaucoma (4) Agitated states (4) History of drug abuse (4) Pregnancy (4, 8.1) Nursing (4, 8.3) Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines (4) Warnings and Precautions Coadministration with other drugs for weight loss is not recommended (safety and efficacy of combination not established)
The gut microbiota, obesity and insulin resistance
Products mentioned were purchased
Clinical trials for erythropoietic protoporphyria used 16mg implants delivering continuous release over 60 days, demonstrating that sustained exposure
